Highlights:
1. Newer, safer and effective treatment regimen and inexpensive, user- friendly rapid diagnostic tests boosts prospects for Kala-azar elimination.
2. Success of single dose Liposomal Amphotericin B, Ambigome, brings early relief and ends compliance- failure faced by the earlier long- term treatment.
3. Collaborative efforts under the 2014 Agreement between 5 affected countries of WHO South-East Asia Region (SEAR) accelerates elimination timeline.
#KalaAzar #Elimination #Disease
|
Publisher:
WHO
,
(2014
) |
Type / Script:
Bulletin or Poster
in English
|
Keywords:
KALA AZAR, LEISHMANIASIS, DIAGNOSTIC SPECIMENS, TROPICAL DISEASES, ENDEMIC DISEASES, ANAEMIA, DISEASES, POVERTY, POVERTY MITIGATION, DEATHS, LEADERSHIP, STAKEHOLDERS, FAMILY WELFARE, HEALTH, RURAL AREAS, CARE WORKERS, CAPACITY BUILDING, CAPACITY DEVELOPMENT, TECHNICAL ASSISTANCE, RESEARCH, TREATMENT, PREGNANT WOMEN, FEVER
|
Thematic Group:
WHO
:
World Health Organization
|
Thesaurus:
10.03.02
- Diseases And Carriers Of Diseases
|
Reference Link:
|
|
|
** This document has been:
1045
times viewed
4
times downloaded. Feeder:
ALISHATHAPALIYA
, Editor:
SANJIYA SHRESTHA
, Auditor:
View Document History
|
|
|
|
|